JAZZ vs PRA · P/E 1988, rev $2.28B vs P/E 20, rev $1.15B
Jazz Pharmaceuticals PLC (JAZZ) versus ProAssurance Corporation (PRA) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
ProAssurance Corporation (PRA) is a insurance - property & casualty company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PRA revenue for 2024-12-31 was $1.15B. Net income was $52.7M. Revenue was up 1.2% from 2023-12-31 to 2024-12-31. PRA currently screens at market cap $1.27B and trailing P/E 19.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PRA currently screens at market cap $1.27B and trailing P/E 19.5.
Not investment advice. Open the JAZZ and PRA stock pages for the full models.
Not investment advice.